Global Chronic Pain Treatment Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Chronic Pain Treatment Market Insights, Forecast to 2034
Chronic pain is pain that carries on for longer than 12 weeks despite medication or treatment. Most people get back to normal after pain following an injury or operation. But sometimes the pain carries on for longer or comes on without any history of an injury or operation.
Market Analysis and InsightsGlobal Chronic Pain Treatment Market
Global Chronic Pain Treatment market is expected to reach to US$ 85920 million in 2024, with a positive growth of %, compared with US$ 79690 million in 2022. Backed with the increasing demand from downstream industries, Chronic Pain Treatment industry is evaluated to reach US$ 126790 million in 2029. The CAGR will be 6.7% during 2024 to 2029.
According to the World Health Organization (WHO), between 2015 and 2050, the proportion of the world's population over the age of 60 will nearly double, from 12% to 22%. In addition, the prevalence of chronic pain in nursing home seniors is very high and has become a serious problem in nursing facilities. Globally, rising prevalence of chronic diseases is one of the major healthcare burdens, affecting high-income as well as low- and middle-income countries. Due to the increasing prevalence of chronic diseases, various treatments such as medication, physical therapy, and psychotherapy are widely used through which pain can be managed.
Report Covers
This report presents an overview of global Chronic Pain Treatment market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Chronic Pain Treatment market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Eli Lilly and Company
GlaxoSmithKline
Pfizer
Medtronic
Abbott Laboratories
Boston Scientific Corporation
Novartis AG
Johnson & Johnson
AstraZeneca PLC
Bristol-Myers Squibb
Becton, Dickinson and Company
Sanofi
Segment by Type
Drugs
Devices
Hospitals
Clinics
Nursing Homes
Research Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Chronic Pain Treatment introduction, etc. Chronic Pain Treatment Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Chronic Pain Treatment
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Market Analysis and InsightsGlobal Chronic Pain Treatment Market
Global Chronic Pain Treatment market is expected to reach to US$ 85920 million in 2024, with a positive growth of %, compared with US$ 79690 million in 2022. Backed with the increasing demand from downstream industries, Chronic Pain Treatment industry is evaluated to reach US$ 126790 million in 2029. The CAGR will be 6.7% during 2024 to 2029.
According to the World Health Organization (WHO), between 2015 and 2050, the proportion of the world's population over the age of 60 will nearly double, from 12% to 22%. In addition, the prevalence of chronic pain in nursing home seniors is very high and has become a serious problem in nursing facilities. Globally, rising prevalence of chronic diseases is one of the major healthcare burdens, affecting high-income as well as low- and middle-income countries. Due to the increasing prevalence of chronic diseases, various treatments such as medication, physical therapy, and psychotherapy are widely used through which pain can be managed.
Report Covers
This report presents an overview of global Chronic Pain Treatment market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Chronic Pain Treatment market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Eli Lilly and Company
GlaxoSmithKline
Pfizer
Medtronic
Abbott Laboratories
Boston Scientific Corporation
Novartis AG
Johnson & Johnson
AstraZeneca PLC
Bristol-Myers Squibb
Becton, Dickinson and Company
Sanofi
Segment by Type
Drugs
Devices
Segment by Application
Hospitals
Clinics
Nursing Homes
Research Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Chronic Pain Treatment introduction, etc. Chronic Pain Treatment Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Chronic Pain Treatment
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports